scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

NEXT STORY
Ascendis Pharma A/S Presents 6-Month Open-Label Extension Data from Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism at ENDO 2021
PREV STORY
Vision Care Market 2021 | To Exhibit a CAGR of 5.6% and Hit USD 192.85 Billion by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Progenics Pharmaceuticals to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference

NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...

author_avatar
NASDAQ Market News

Surface Oncology Recognized as one of the “Best Places to Work” by Boston Business Journal

CAMBRIDGE, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology ...

author_avatar
NASDAQ Market News

Coherus BioSciences Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Sept. 16, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News